Drug:
Reaction: NEUTROPENIA
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25040701 |
US |
1 | |
Neutropenia, |
||||
| 502 | 25040748 |
PL |
67 | 1 |
Neutropenia, Anaemia, |
||||
FLUOROURACIL, FLUOROURACIL, |
||||
| 503 | 25040774 |
FR |
45 | 2 |
Gastrointestinal toxicity, Nausea, Vomiting, Dehydration, Acute kidney injury, Neutropenia, |
||||
CARBOPLATIN, PEMETREXED DISODIUM, NIVOLUMAB, CARBOPLATIN, |
||||
| 504 | 25040796 |
IT |
69 | 1 |
Neutropenia, Neuropathy peripheral, Dysgeusia, |
||||
FLUOROURACIL, BEVACIZUMAB, |
||||
| 505 | 25040810 |
AU |
||
Anaemia, Cardio-respiratory arrest, Diarrhoea, Dyspnoea, Fatigue, Insomnia, Nausea, Neuropathy peripheral, Neutropenia, Oedema peripheral, Plasma cell myeloma refractory, Pneumonia, Therapy partial responder, Thrombocytopenia, Tumour lysis syndrome, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, THALIDOMIDE, |
||||
| 506 | 25041068 |
AT |
8 | 1 |
Hospitalisation, Neutropenia, Thrombocytopenia, Neuropathy peripheral, Intentional product use issue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, CARFILZOMIB, |
||||
| 507 | 25041315 |
US |
||
Neutropenia, |
||||
ASCIMINIB, NILOTINIB, |
||||
| 508 | 25041661 |
TR |
21 | 1 |
Neutropenia, Haemophilus infection, Bacterial sepsis, Bronchopulmonary aspergillosis, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, MICAFUNGIN, MICAFUNGIN SODIUM, ETOPOSIDE, FLUDARABINE PHOSPHATE, NELARABINE, NELARABINE INJECTION, AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, |
||||
| 509 | 25042115 |
FR |
||
Haematological malignancy, Cataract, Neutropenia, Pneumonia, Neoplasm, Peripheral sensory neuropathy, Diarrhoea, Upper respiratory tract infection, Infection, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 510 | 25042250 |
RO |
20 | 2 |
Neutropenia, Multisystem inflammatory syndrome, |
||||
CEMIPLIMAB-RWLC, CEMIPLIMAB-RWLC, |
||||
| 511 | 25042280 |
TW |
88 | 2 |
Neutropenia, |
||||
| 512 | 25042405 |
US |
78 | 1 |
Neutropenia, |
||||
PACLITAXEL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DENOSUMAB, |
||||
| 513 | 25042645 |
IT |
68 | 1 |
Neutropenia, Eczema, Cough, |
||||
LENALIDOMIDE, |
||||
| 514 | 25042796 |
DK |
2 | |
Neutropenia, Platelet count decreased, Off label use, |
||||
RIBOCICLIB, FULVESTRANT, |
||||
| 515 | 25042969 |
DE |
2 | |
Neutropenia, Weight increased, Neutropenia, Leukopenia, Neutropenia, Neutropenia, Neutropenia, Cystitis, Hypertension, Hypertension, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 516 | 25043006 |
JP |
73 | 1 |
Hyponatraemia, Malignant neoplasm progression, Hypokalaemia, Neutropenia, |
||||
PEMBROLIZUMAB, CISPLATIN, FLUOROURACIL, |
||||
| 517 | 25043051 |
JP |
75 | 1 |
Malignant neoplasm progression, Neutropenia, Therapeutic response decreased, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, CYCLOSPORINE, CYCLOSPORINE, |
||||
| 518 | 25034343 |
US |
||
Transplantation complication, Death, Acute lymphocytic leukaemia recurrent, Neutropenia, Sepsis, Febrile neutropenia, Bacteraemia, Pneumonia, Urinary tract infection, Pneumonia, Diarrhoea, Colitis, Infection, Hyperglycaemia, Hypocalcaemia, Hypotension, Thrombocytopenia, |
||||
PEGFILGRASTIM, PREDNISONE, BLINATUMOMAB, RITUXIMAB, VENETOCLAX, |
||||
| 519 | 25034637 |
JP |
8 | 1 |
Dyspepsia, Torsade de pointes, Hypomagnesaemia, Oxygen saturation decreased, Anaemia, Fatigue, Neutropenia, Diarrhoea, Arthralgia, Hyperventilation, Heart rate increased, Tremor, Renal impairment, Dizziness, Aspartate aminotransferase increased, Alanine aminotransferase increased, Drug ineffective, |
||||
LANSOPRAZOLE, LANSOPRAZOLE, CARBOPLATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FAMOTIDINE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, PACLITAXEL, OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS CAPSULES, AMLODIPINE, TELMISARTAN, BISOPROLOL FUMARATE, |
||||
| 520 | 25034678 |
US |
59 | 2 |
Neutropenia, Anaemia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PACLITAXEL, PACLITAXEL, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NIVOLUMAB, NIVOLUMAB, CAPECITABINE, CAPECITABINE, |
||||
| 521 | 25034681 |
US |
62 | 1 |
Neutropenia, Pyrexia, Chills, Nausea, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PACLITAXEL, PACLITAXEL, PACLITAXEL, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 522 | 25034878 |
US |
62 | 1 |
Pyrexia, Chills, Nausea, Neutropenia, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, PEMBROLIZUMAB, |
||||
| 523 | 25034915 |
US |
7 | 1 |
Death, Bacteraemia, Pericardial effusion, Septic shock, Neutropenia, Drug interaction, Dyspnoea, Hepatosplenomegaly, Cough, Oedema peripheral, |
||||
POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, AZACITIDINE, AZACITIDINE FOR, RUXOLITINIB, MICAFUNGIN, MICAFUNGIN SODIUM, PACRITINIB, PACRITINIB, PACRITINIB, |
||||
| 524 | 25035129 |
PL |
56 | 1 |
Neutropenia, |
||||
CISPLATIN, FLUOROURACIL, |
||||
| 525 | 25035226 |
FR |
65 | 1 |
Neutropenia, |
||||
PANTOPRAZOLE, ISAVUCONAZONIUM SULFATE, SPIRONOLACTONE, CHOLESTYRAMINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LACTULOSE, FUROSEMIDE, |
||||
| 526 | 25035503 |
FR |
63 | 2 |
Colitis, Diarrhoea, Neutropenia, Rash, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, AMIVANTAMAB, AMIVANTAMAB, |
||||
| 527 | 25035665 |
US |
||
Acute kidney injury, Glomerular filtration rate decreased, Neutropenia, |
||||
SELINEXOR, ACYCLOVIR, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, APIXABAN, BACLOFEN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FINASTERIDE, GABAPENTIN, LISINOPRIL, LORATADINE, LORATADINE ORAL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MORPHINE SULFATE, OLANZAPINE, |
||||
| 528 | 25035703 |
US |
78 | 1 |
Neutropenia, |
||||
PACLITAXEL, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DENOSUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 529 | 25035829 |
56 | 2 | |
Platelet count decreased, Epistaxis, Neutropenia, Cerebral microhaemorrhage, |
||||
CYTARABINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 530 | 25035886 |
PL |
58 | 1 |
Neutropenia, Anaemia, |
||||
CISPLATIN, FLUOROURACIL, |
||||
| 531 | 25035979 |
IT |
52 | 1 |
Neutropenia, Off label use, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 532 | 25036153 |
FR |
2 | |
Neutropenia, Hepatic cytolysis, Nutritional condition abnormal, Off label use, |
||||
CRIZOTINIB, |
||||
| 533 | 25036164 |
JP |
69 | 1 |
Neuropathy peripheral, Neutropenia, Off label use, |
||||
BEVACIZUMAB, BEVACIZUMAB, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL, FLUOROURACIL, |
||||
| 534 | 25036338 |
CA |
70 | 1 |
Amnesia, Hypertension, Neutropenia, Off label use, Platelet count abnormal, Sensitive skin, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 535 | 25036359 |
1 | ||
Neutropenia, Pneumonia viral, Pulmonary artery dilatation, Pulmonary arterial hypertension, |
||||
LENALIDOMIDE, |
||||
| 536 | 25036494 |
CN |
59 | 2 |
Neutropenia, Platelet count decreased, |
||||
| 537 | 25036508 |
IT |
73 | 2 |
Diarrhoea, Neutropenia, Drug ineffective, Paraesthesia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, RAMIPRIL, RAMIPRIL, ROSUVASTATIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, PACLITAXEL, CARBOPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, PANTOPRAZOLE, CAPECITABINE, VINORELBINE, |
||||
| 538 | 25036512 |
FR |
75 | 1 |
Pneumonia respiratory syncytial viral, Prostate cancer, Neutropenia, Hypokalaemia, COVID-19, Diarrhoea, Nausea, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, LANSOPRAZOLE, APIXABAN, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, COLCHICINE, FAMOTIDINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FESOTERODINE FUMARATE, FENOFIBRATE, |
||||
| 539 | 25036653 |
US |
43 | 1 |
Infection, Diabetic ketoacidosis, Neutropenia, Thrombocytopenia, Septic shock, |
||||
CAPECITABINE, OXALIPLATIN, |
||||
| 540 | 25036956 |
MX |
||
Bacterial sepsis, Neutropenia, |
||||
FILGRASTIM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MESNA, MESNA INJECTION, RITUXIMAB, ACYCLOVIR, ITRACONAZOLE, |
||||
| 541 | 25037006 |
IN |
52 | 1 |
Toxicity to various agents, Neutropenia, Off label use, Product use issue, |
||||
BRENTUXIMAB VEDOTIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DACARBAZINE, |
||||
| 542 | 25037092 |
JP |
40 | 2 |
Neutropenia, |
||||
PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, |
||||
| 543 | 25037113 |
RU |
54 | 2 |
Myeloma cast nephropathy, Neutropenia, Thrombocytopenia, Polyneuropathy, Secondary immunodeficiency, Upper respiratory tract infection, |
||||
DARATUMUMAB, BORTEZOMIB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 544 | 25037347 |
DE |
59 | 2 |
Myelosuppression, Neutropenia, Alanine aminotransferase decreased, Pyrexia, Anaemia, |
||||
ABEMACICLIB, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 545 | 25037596 |
US |
2 | |
Neutropenia, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 546 | 25037817 |
US |
45 | 2 |
Peripheral sensory neuropathy, Diarrhoea, Neutropenia, Bacteraemia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, BRENTUXIMAB VEDOTIN, NELARABINE, NELARABINE INJECTION, IDARUBICIN HYDROCHLORIDE, CYTARABINE, FLUDARABINE PHOSPHATE, VENETOCLAX, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 547 | 25037936 |
DE |
46 | 1 |
Fatigue, Neutropenia, |
||||
CARFILZOMIB, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, ACYCLOVIR, ACYCLOVIR, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 548 | 25037956 |
IT |
73 | 2 |
Neutropenia, Off label use, |
||||
LENALIDOMIDE, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 549 | 25037982 |
PL |
72 | 2 |
Neutropenia, Hepatotoxicity, Aspartate aminotransferase increased, Alanine aminotransferase increased, Bone lesion, Hiatus hernia, |
||||
RIBOCICLIB, ZOLEDRONIC ACID, |
||||
| 550 | 25038140 |
IT |
74 | 2 |
Neutropenia, Gastrointestinal disorder, |
||||
LENALIDOMIDE, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 551 | 25038175 |
DE |
46 | 1 |
Neutropenia, Fatigue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, CARFILZOMIB, LENALIDOMIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ACYCLOVIR, |
||||
| 552 | 25038200 |
IE |
||
Neutropenia, |
||||
OFATUMUMAB, |
||||
| 553 | 25038246 |
US |
84 | 2 |
Neutropenia, |
||||
PALBOCICLIB, |
||||
| 554 | 25038469 |
US |
62 | 1 |
Neutropenia, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CISPLATIN, PEMBROLIZUMAB, |
||||
| 555 | 25038473 |
CA |
84 | 2 |
Death, Neutropenia, |
||||
CLOZAPINE, |
||||
| 556 | 25038479 |
CA |
44 | 1 |
Death, Neutropenia, |
||||
CLOZAPINE, |
||||
| 557 | 25040745 |
86 | 2 | |
Neutropenia, |
||||
| 558 | 25029802 |
JP |
70 | 1 |
Seizure, Neutropenia, Hyperglycaemia, Urinary tract infection, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 559 | 25029919 |
US |
62 | 1 |
Neutropenia, Pyrexia, Chills, Nausea, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PACLITAXEL, PACLITAXEL, PACLITAXEL, CISPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PEMBROLIZUMAB, |
||||
| 560 | 25029930 |
US |
||
Pyrexia, Chills, Nausea, Neutropenia, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, CISPLATIN, CISPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 561 | 25030128 |
US |
||
Neutropenia, Febrile neutropenia, Thrombocytopenia, Infection, Adverse event, |
||||
PREDNISONE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, OBINUTUZUMAB, VENETOCLAX, |
||||
| 562 | 25030183 |
US |
||
Neutropenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, |
||||
| 563 | 25030537 |
MX |
2 | |
Neutropenia, Mouth ulceration, |
||||
OCRELIZUMAB, |
||||
| 564 | 25030650 |
IN |
36 | 2 |
Neutropenia, |
||||
CISPLATIN, FLUOROURACIL, |
||||
| 565 | 25030673 |
AU |
61 | 1 |
Bacteraemia, Device related bacteraemia, Febrile neutropenia, Neutropenia, Neutropenic sepsis, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, CYCLOSPORINE, IDARUBICIN HYDROCHLORIDE, VENETOCLAX, |
||||
| 566 | 25030681 |
IT |
77 | 1 |
Dysphagia, Neutropenia, Vomiting, |
||||
CARBOPLATIN, PACLITAXEL, |
||||
| 567 | 25030793 |
ES |
65 | 2 |
Neutropenia, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
| 568 | 25030886 |
CA |
60 | 2 |
Neutropenia, Lymphocyte count decreased, Red blood cell count increased, Mean cell volume decreased, Mean cell haemoglobin decreased, Mean cell haemoglobin concentration decreased, Red cell distribution width increased, White blood cell count decreased, Off label use, |
||||
RIBOCICLIB, RIBOCICLIB, |
||||
| 569 | 25030916 |
GB |
2 | |
Colon cancer, Neutropenia, Eosinophil count decreased, Neutrophil count increased, White blood cell count increased, |
||||
CLOZAPINE, CLOZAPINE, DIVALPROEX SODIUM, |
||||
| 570 | 25030920 |
PL |
77 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 571 | 25031008 |
ES |
68 | 2 |
Neutropenic colitis, Pancytopenia, Neutropenia, Thrombocytopenia, Bronchopulmonary aspergillosis, Pneumonia, Intervertebral discitis, Hepatotoxicity, Photosensitivity reaction, Off label use, |
||||
CAPECITABINE, OXALIPLATIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, MEROPENEM, VORICONAZOLE, VORICONAZOLE, VORICONAZOLE, AMPHOTERICIN B, |
||||
| 572 | 25031099 |
FR |
2 | 2 |
Pneumocystis jirovecii pneumonia, Neutropenia, Cytomegalovirus infection reactivation, Hypogammaglobulinaemia, Hepatitis B, Measles, Varicella, Off label use, Off label use, Haematotoxicity, |
||||
DARATUMUMAB, OBINUTUZUMAB, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, RITUXIMAB, |
||||
| 573 | 25031120 |
PL |
70 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 574 | 25031568 |
PL |
72 | 2 |
Neutropenia, Hepatotoxicity, Aspartate aminotransferase increased, Alanine aminotransferase increased, Bone lesion, Hiatus hernia, |
||||
RIBOCICLIB, ZOLEDRONIC ACID, |
||||
| 575 | 25031571 |
74 | 2 | |
Product dispensing error, Product prescribing error, Inappropriate schedule of product administration, Product communication issue, General physical health deterioration, Haemoptysis, Anaemia, Thrombocytopenia, Neutropenia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 576 | 25031603 |
US |
4 | 1 |
Mucosal inflammation, Acute kidney injury, Neutropenia, Thrombocytopenia, Oedema peripheral, Drug clearance decreased, Drug interaction, |
||||
IMATINIB, IMATINIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 577 | 25031645 |
RO |
70 | 2 |
Neutropenia, Pneumonia, Haematotoxicity, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 578 | 25031878 |
AR |
35 | 1 |
Neutropenia, Neutrophil count increased, White blood cell count decreased, Lymphocyte count increased, Monocyte count decreased, |
||||
CLOZAPINE, CLOZAPINE, SERTRALINE, FINASTERIDE, |
||||
| 579 | 25031954 |
US |
61 | 2 |
Neutropenia, Anaemia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PACLITAXEL, PACLITAXEL, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, |
||||
| 580 | 25032198 |
GR |
52 | 2 |
Neutropenia, Accidental overdose, |
||||
RIBOCICLIB, |
||||
| 581 | 25032223 |
ES |
75 | 1 |
Neutropenia, Unevaluable event, Bone pain, |
||||
FILGRASTIM, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 582 | 25032434 |
US |
23 | 1 |
Granulocytopenia, Aggression, Illness, Hospitalisation, Product dose omission issue, Neutropenia, |
||||
CLOZAPINE, CLOZAPINE, HUMAN IMMUNOGLOBULIN G, |
||||
| 583 | 25032449 |
FR |
63 | 2 |
Diarrhoea, Rash, Colitis, Neutropenia, |
||||
PEMETREXED, PEMETREXED DISODIUM, AMIVANTAMAB, AMIVANTAMAB, CARBOPLATIN, |
||||
| 584 | 25032503 |
SG |
||
Death, Fatigue, Insomnia, Leukopenia, Neutropenia, Malignant biliary obstruction, Ascites, |
||||
NIRAPARIB, NIRAPARIB, |
||||
| 585 | 25032591 |
US |
43 | 1 |
Septic shock, Diabetic ketoacidosis, Dysphagia, Drug ineffective, Neutropenia, Toxicity to various agents, Asthenia, Decreased appetite, Vomiting, Abdominal pain, Rash, Oral pain, Nausea, Diarrhoea, Thrombocytopenia, |
||||
CAPECITABINE, OXALIPLATIN, URIDINE TRIACETATE, |
||||
| 586 | 25032681 |
BG |
31 | 2 |
COVID-19, Neutropenia, Metastases to central nervous system, Memory impairment, Haematotoxicity, Therapy partial responder, |
||||
TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, DENOSUMAB, DENOSUMAB, DENOSUMAB, DENOSUMAB, DENOSUMAB, DENOSUMAB, DENOSUMAB, PROGESTERONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ZOLEDRONIC ACID, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, GOSERELIN, GOSERELIN, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, |
||||
| 587 | 25032970 |
FR |
37 | |
Drug ineffective, Neutropenia, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, |
||||
| 588 | 25033061 |
IT |
79 | 1 |
Neutropenia, Aggression, Eye pain, Constipation, Asthenia, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, |
||||
| 589 | 25033130 |
IT |
31 | 2 |
Neutropenia, Rash, Alanine aminotransferase increased, |
||||
RIFAMPIN, RIFAMPIN, RIFAMPIN, |
||||
| 590 | 25033259 |
FI |
54 | 2 |
Neutropenia, Leukopenia, Rash, Fatigue, Chest pain, |
||||
CLOZAPINE, LISINOPRIL, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, |
||||
| 591 | 25033296 |
CA |
2 | |
Death, Neutropenia, Neutrophil count increased, |
||||
CLOZAPINE, |
||||
| 592 | 25033327 |
RO |
56 | 2 |
Nausea, Neutropenia, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 593 | 25033396 |
CA |
62 | 2 |
Drug resistance, Neutropenia, Oropharyngeal pain, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CLOZAPINE, CLOZAPINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, LACTULOSE, LACTULOSE, LACTULOSE, LACTULOSE, LACTULOSE, LACTULOSE, MIRTAZAPINE, OLANZAPINE, OLANZAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RISPERIDONE, RISPERIDONE, SENNOSIDES, SENNOSIDES, SENNOSIDES, SENNOSIDES, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 594 | 25033804 |
US |
74 | 1 |
Neutropenia, |
||||
| 595 | 25033809 |
US |
25 | 1 |
Agranulocytosis, Neutropenia, C-reactive protein abnormal, Treatment noncompliance, Salivary hypersecretion, |
||||
CLOZAPINE, CLOZAPINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 596 | 25028537 |
PL |
83 | 2 |
Neutropenia, Hyponatraemia, Asthenia, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, |
||||
| 597 | 25028582 |
PT |
69 | 2 |
Neutropenia, Pancreatitis acute, Respiratory tract infection, White blood cell count decreased, |
||||
EZETIMIBE, ABEMACICLIB, ABEMACICLIB, LISINOPRIL, SERTRALINE, ALPRAZOLAM, SIMVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 598 | 25028631 |
PL |
75 | 1 |
Neutropenia, Oral fungal infection, |
||||
OXALIPLATIN, FLUOROURACIL, FLUOROURACIL, |
||||
| 599 | 25028829 |
CN |
10 | 2 |
Hepatotoxicity, Neutropenia, |
||||
PEGFILGRASTIM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 600 | 25025688 |
IT |
56 | 1 |
Febrile neutropenia, Groin abscess, Off label use, Sepsis, Neutropenia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, DECITABINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28